Arterial Stent Market was valued at USD 7.5 Billion in 2022 and is projected to reach USD 10.6 Billion by 2030, growing at a CAGR of 4.6% from 2024 to 2030.
The global arterial stent market has been experiencing rapid advancements in recent years. Driven by technological innovations, the increasing prevalence of cardiovascular diseases, and rising healthcare needs, the arterial stent market has become one of the most dynamic segments of the medical device industry. The following article delves into detailed insights regarding the arterial stent market, discussing its growth trends, key drivers, challenges, and future opportunities.
Arterial stents are small, mesh-like tubes that are inserted into narrowed or blocked arteries to keep them open, allowing better blood flow. These devices are critical in the treatment of various cardiovascular conditions, including coronary artery disease (CAD), peripheral artery disease (PAD), and carotid artery disease (CAD). The arterial stent market primarily includes coronary stents, peripheral stents, and carotid artery stents, which cater to the growing demand for minimally invasive procedures.
As of 2025, the market is expected to continue growing at a significant pace. Several factors, such as the aging global population, advancements in stent technology, increasing incidences of lifestyle-related diseases, and improved healthcare infrastructure, are expected to drive the market forward. Market research suggests that the global arterial stent market will experience a compound annual growth rate (CAGR) of around 7.2% from 2023 to 2030, reaching a valuation of approximately USD 12 billion by the end of the forecast period.
The number of patients suffering from cardiovascular diseases (CVDs) is on the rise globally. According to the World Health Organization (WHO), CVDs are responsible for more than 17.9 million deaths annually, accounting for 31% of all global deaths. This growing burden of heart-related diseases has significantly contributed to the demand for effective treatment options like arterial stents. As the global population ages, the incidence of cardiovascular diseases is likely to increase further, providing substantial growth opportunities for the arterial stent market.
Advances in stent design and materials have drastically improved the functionality and performance of arterial stents. The introduction of drug-eluting stents (DES) and bioresorbable stents (BRS) has revolutionized the market by offering better patient outcomes and reducing complications. These new-age stents are designed to release medication that prevents the narrowing of arteries (restenosis) after a stent procedure. The shift towards more sophisticated stent designs and materials is expected to propel market growth in the coming years.
The growing preference for minimally invasive procedures is another key factor driving the arterial stent market. Stent implantation is a non-surgical procedure performed through catheters, which reduces the risk of infection, minimizes recovery time, and lowers healthcare costs. The convenience and effectiveness of these procedures make stent implantation highly preferred by both patients and healthcare providers, thus stimulating market demand.
Governments and private entities around the world are increasing their healthcare investments, particularly in emerging economies. With better access to healthcare services and higher disposable incomes in regions like Asia-Pacific, there is an increasing focus on cardiovascular treatments, which drives the demand for stents. Rising healthcare expenditure, coupled with improving healthcare infrastructure, will continue to fuel the expansion of the arterial stent market.
Despite advancements in stent technology, the high cost of stent implantation remains one of the most significant challenges in the market. While drug-eluting stents offer superior performance, their high price limits accessibility, especially in low-income countries and underdeveloped regions. This cost barrier is particularly significant when considering the number of stent implants needed globally to treat a growing number of patients with cardiovascular diseases.
While stents have improved patient outcomes significantly, the risk of complications such as restenosis, thrombosis, and allergic reactions to stent materials persists. These complications may require further treatments, hospitalizations, and surgeries, adding to the overall cost of care. As stents become more advanced, medical professionals continue to face the challenge of managing these risks effectively.
Regulatory processes for medical devices, including arterial stents, vary significantly across different regions. While some regions, like the United States and the European Union, have established clear regulatory pathways for medical devices, others may present more challenges due to stricter approval processes, which can delay market entry for new products. Navigating these regulatory barriers can be a significant hurdle for companies seeking to introduce innovative stent products globally.
The arterial stent market can be segmented based on product type, material type, and end-user.
Coronary Stents: These are the most widely used stents in the market, designed specifically for the treatment of coronary artery disease (CAD). The growing prevalence of CAD has contributed to the dominance of coronary stents in the market.
Peripheral Stents: Used to treat peripheral artery disease (PAD), these stents are gaining traction as the prevalence of PAD increases globally, particularly in aging populations.
Carotid Artery Stents: These stents are used in the treatment of carotid artery disease, a condition that can lead to strokes. The growing focus on stroke prevention is expected to drive the demand for these stents.
Metal Stents: These are traditional stents made from stainless steel or cobalt-chromium alloys. They are widely used but are gradually being replaced by drug-eluting and bioresorbable stents.
Drug-Eluting Stents (DES): These stents are coated with medication that helps prevent restenosis. They have become the standard in the market due to their effectiveness.
Bioresorbable Stents (BRS): These stents dissolve over time and offer an advantage in terms of eliminating the need for long-term stent implantation.
Hospitals: Hospitals are the leading end-users of arterial stents due to their advanced medical infrastructure and a high number of procedures performed.
Ambulatory Surgical Centers: These centers are gaining popularity for stent procedures due to their cost-effectiveness and the growing trend of outpatient surgeries.
Cardiac Catheterization Labs: These specialized labs are equipped with the necessary tools and technology to perform stent procedures and are a key part of the healthcare system.
North America is the largest market for arterial stents, driven by factors such as the high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and increasing adoption of innovative stent technologies. The United States, in particular, holds a significant share of the market due to the well-established healthcare system, high healthcare expenditure, and rising adoption of minimally invasive procedures.
Europe is another major market, with countries such as Germany, the UK, and France leading the way in terms of arterial stent usage. The region is characterized by the increasing demand for high-quality healthcare services and a growing elderly population, both of which contribute to the demand for arterial stents.
The Asia-Pacific region is expected to witness the highest growth in the arterial stent market, driven by improving healthcare infrastructure, rising disposable incomes, and an increasing number of people suffering from cardiovascular diseases. Emerging economies like India and China are seeing a surge in the demand for stents as the awareness and accessibility of healthcare services increase.
These regions are also poised to experience steady growth in the arterial stent market, fueled by expanding healthcare access, rising healthcare expenditure, and increasing incidences of cardiovascular diseases. However, the market in these regions faces challenges such as high treatment costs and regulatory hurdles.
The arterial stent market is highly competitive, with key players constantly innovating to offer superior products. Some of the leading companies in this market include:
Boston Scientific Corporation
Medtronic PLC
Abbott Laboratories
Johnson & Johnson (Ethicon)
Terumo Corporation
These companies focus on research and development activities to create more effective, safer, and cost-efficient stents. Additionally, many market players are forming strategic partnerships and collaborations to enhance their product portfolios and expand their market presence.
The arterial stent market is expected to experience robust growth over the next few years, driven by factors such as the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive procedures. However, challenges like high costs, regulatory hurdles, and complications associated with stent implantation could potentially hinder market progress. As the market evolves, companies will need to continue innovating and addressing these challenges to maintain their competitive edge and capitalize on the growing demand for arterial stents.
Download Full PDF Sample Copy of Global Arterial Stent Report @ https://www.verifiedmarketreports.com/download-sample/?rid=481615&utm_source=Google-Site-Feb&utm_medium=229
Abbott Laboratories
Cordis Corporation
Boston Scientific Corporation
C.R. Bard Inc.
Cook Medical
Medtronic
Gore Medical
Lifetech Scientific
Biosensors International Group Ltd.
Biotronik AG
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase Of This Report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=481615&utm_source=Google-Site-Feb&utm_medium=229
Growing demand for below applications around the world has had a direct impact on the growth of the Global Arterial Stent Market
Iliac Artery
Carotid Artery
Coronary Artery
Femoral & Popliteal Artery
Other
Based on Types the Market is categorized into Below types that held the largest Arterial Stent market share In 2023.
Coronary Stents
Peripheral Stents
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ https://www.verifiedmarketreports.com/product/arterial-stent-market-size-and-forecast/
1. Introduction of the Global Arterial Stent Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Arterial Stent Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Arterial Stent Market, By Type
6. Global Arterial Stent Market, By Application
7. Global Arterial Stent Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Arterial Stent Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/